Unicycive Therapeutics, Inc. (UNCY) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -6.24M | -8.03M | -5.96M | -8.42M | -8.9M | -6.55M | -9.25M | -6.32M | -6.46M | -4.44M | -4.42M | -5.5M | -3.92M | -6.08M | -3.56M | -3.05M | -2.96M | -1.4M | -3.47M | -217K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -580.74% | - | -374.66% | - | - | - | - | - |
| Operating CF Growth % | 29.9% | -22.66% | 35.56% | -33.25% | -37.9% | -47.51% | -109.23% | -14.85% | -64.69% | 27.04% | -24.11% | -80.57% | -32.57% | -333.64% | -2.56% | -1304.15% | -339.38% | -160.78% | -392.07% | -52.82% |
| Net Income | -12.82M | -14.67M | -6.01M | -6.45M | 570K | -21.52M | -4.1M | 9.86M | -20.96M | -7.8M | -4.33M | -3.84M | -14.57M | -5.33M | -5.56M | -3.64M | -3.54M | -2.75M | -5.2M | -1.1M |
| Depreciation & Amortization | 211K | 151K | 148K | 138K | 135K | 134K | 123K | -113K | 284K | 82K | 79K | 78K | 45K | 42K | 40K | 40K | 39K | 1K | 0 | 0 |
| Stock-Based Compensation | 754K | 777K | 0 | 571K | 563K | 582K | 605K | 641K | 522K | 550K | 929K | 144K | 144K | 197K | 266K | 294K | 290K | 0 | 239K | 294K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.65M | -406K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.81M | 7.77M | -336K | -374K | -8.35M | 12.56M | -1.75M | -17.18M | 11.81M | 1.61M | -1.4M | -282K | 10.38M | 21K | -1.65M | 406K | 0 | 140K | 2.77M | 441K |
| Working Capital Changes | 807K | -2.06M | 237K | -2.31M | -1.82M | 1.7M | -4.13M | 480K | 1.89M | 1.12M | 299K | -1.6M | 91K | -1.02M | 1.69M | 255K | 251K | 1.21M | -1.28M | 148K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.29M | -1.81M | 775K | -2.26M | 791K | 971K | 0 | 0 | 0 | 427K | 1.48M | 0 | -193K | -641K | 1.95M | -70K | 24K | 778K | 443K | 103K |
| Cash from Investing | -5.16M | -12.07M | -2K | -6K | -16K | -22K | -24K | -20K | -6K | 0 | 0 | -12K | 0 | -2K | 0 | 0 | -2K | -29K | 0 | 0 |
| Capital Expenditures | -8K | 0 | -2K | -6K | -16K | -22K | -24K | -20K | -6K | 0 | 0 | -12K | 0 | -2K | 0 | 0 | -2K | -29K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 19.57M | 6.61M | 26.33M | 10.98M | 2.55M | 365K | -157K | -811K | 45.69M | -205K | -51K | 0 | 27.8M | -471K | 0 | 0 | 0 | 0 | 21.48M | 71K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -890K | 174K |
| Equity Issued (Net) | 19.57M | 5.41M | 27.15M | 9.83M | 2.79M | 523K | 0 | 0 | 50M | 0 | 0 | 0 | 30.19M | 11K | 0 | 0 | 0 | 0 | 22.27M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 1.19M | -815K | 1.15M | -244K | -158K | -157K | 284K | -4.31M | -205K | -51K | 0 | -2.39M | -482K | 0 | 0 | 0 | 0 | 103K | -103K |
| Net Change in Cash | 8.17M | -13.5M | 20.37M | 2.56M | -6.37M | -6.21M | -9.43M | -7.15M | 39.23M | -4.64M | -4.47M | -5.51M | 23.88M | -6.55M | -3.56M | -3.05M | -2.96M | -1.43M | 18.01M | -146K |
| Free Cash Flow | -6.25M | -8.03M | -5.96M | -8.43M | -8.92M | -6.57M | -9.28M | -6.34M | -6.46M | -4.44M | -4.42M | -5.51M | -3.92M | -6.09M | -3.56M | -3.05M | -2.96M | -1.43M | -3.47M | -217K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | -580.74% | - | -374.66% | - | - | - | - | - |
| FCF Growth % | 29.94% | -22.25% | 35.7% | -32.92% | -38.02% | -48.01% | -109.77% | -14.96% | -64.85% | 27.06% | -24.11% | -80.96% | -32.48% | -325% | -2.56% | -1304.15% | -339.67% | -166.17% | -392.07% | -52.82% |
| FCF per Share | -0.03 | -0.05 | -0.33 | -0.68 | -0.72 | -0.98 | -1.04 | -0.67 | -1.85 | -1.28 | -1.36 | -3.62 | -2.57 | -4.00 | -2.37 | -2.03 | -1.97 | -1.01 | -0.25 | -0.16 |
| FCF Conversion (FCF/Net Income) | 0.49x | 0.55x | 0.99x | 1.31x | -15.62x | 0.30x | 2.26x | -0.64x | 0.31x | 0.57x | 1.02x | 1.43x | 0.27x | 1.14x | 0.64x | 0.84x | 0.84x | 0.51x | 0.67x | 0.20x |
| Interest Paid | 0 | 0 | 0 | 3K | 0 | 0 | 15K | 31K | 5K | 0 | -44K | 44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |